| Issue | Title | |
| Vol 8, No 2 (2015) | SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract PDF (Rus) |
| Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii | ||
| Vol 9, No 1 (2016) | SYSTEMATIC REVIEW OF PENTAGLOBIN EFFICACY IN PREVENTING MORTALITY IN NEWBORNS AND OLDER CHILDREN WITH BACTERIAL INFECTIONS AND SEPSIS | Abstract PDF (Rus) |
| V. K. Fedyaeva, O. Yu. Rebrova | ||
| Vol 5, No 2 (2012) | THE ANALYSIS OF COST OF ILLNESS OF PREGNANT WOMEN WITH SYPHILIS | Abstract PDF (Rus) |
| A. I. Ovod, M. D. Mukovnina | ||
| Vol 7, No 3 (2014) | THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT | Abstract PDF (Rus) |
| V. I. Ignatyeva, M. V. Avxentyeva | ||
| Vol 15, No 1 (2022) | The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 | Abstract PDF (Rus) |
| I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova | ||
| Vol 7, No 2 (2014) | THE ANALYSIS OF THE EFFECTIVENESS OF THROMBOPROPHYLAXIS AMONG PREGNANT WOMEN WITH MESENCHYMAL DYSPLASIA | Abstract PDF (Rus) |
| E. G. Kudinova, A. P. Momot, N. V. Trukhacheva | ||
| Vol 7, No 2 (2014) | THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID | Abstract PDF (Rus) |
| K. V. Danilova, I. M. Razdorskaya | ||
| Vol 6, No 3 (2013) | THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT | Abstract PDF (Rus) |
| N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova | ||
| Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract PDF (Rus) |
| V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
| Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract PDF (Rus) |
| M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
| Vol 8, No 4 (2015) | THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA | Abstract PDF (Rus) |
| K. V. Gerasimova, M. V. Avxentyeva, I. A. Belyaeva | ||
| Vol 9, No 4 (2016) | THE COSTS OF REGIONAL ANESTHESIA WITH THE USE OF LEVOBUPIVACAINE, RACEMIC BUPIVACAINE AND ROPIVACAINE | Abstract PDF (Rus) |
| G. E. Ulrikh, A. V. Rudakova | ||
| Vol 15, No 2 (2022) | The current state of the veterinary drugs market in the Tyumen Region | Abstract PDF (Rus) |
| V. V. Byshenko, О. I. Knysh, L. N. Zadirachenko, А. О. Egorova, Yu. S. Rodina | ||
| Vol 17, No 2 (2024) | The effectiveness of rehabilitation in vulvovaginal atrophy | Abstract PDF (Rus) |
| D. М. Ampilogova, А. G. Solopova, D. V. Blinov, А. Е. Ivanov, S. V. Khlopkova, G. К. Bykovshchenko | ||
| Vol 18, No 1 (2025) | The effectiveness of using artificial intelligence in clinical medicine | Abstract PDF (Rus) |
| D. I. Korabelnikov, A. I. Lamotkin | ||
| Vol 13, No 3 (2020) | The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation | Abstract PDF (Rus) |
| D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova | ||
| Vol 6, No 1 (2013) | THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION | Abstract |
| A. Yu. Kulikov, Yu. L. Akimova | ||
| Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
| Vol 17, No 3 (2024) | The influence of the combination of methanolic extract Scurrula atropurpurea (Blume) and Dendrophthoe pentandra on rat liver function and structure | Abstract PDF (Eng) |
| N. Athiroh, N. J. Mubarakati, Yu. Purnomo | ||
| Vol 10, No 4 (2017) | THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT | Abstract PDF (Rus) |
| D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov | ||
| Vol 17, No 4 (2024) | The joint use of ABC/VEN analysis and the Beers criteria for optimizing expenditure of funds and rational prescribing of medications to elderly patients | Abstract PDF (Rus) |
| O. A. Makhmudova, G. F. Avkhadieva, O. G. Bagdanova, V. N. Khaziakhmetova | ||
| Vol 6, No 3 (2013) | THE MONITORING RESEARCHES OF HIV/AIDS ON THE BASIS OF THE SITUATION ANALYSIS | Abstract PDF (Rus) |
| N. B. Dremova, I. V. Alekseev | ||
| Vol 13, No 1 (2020) | The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung | Abstract PDF (Rus) |
| S. K. Yarovoy, I. B. Shikina | ||
| Vol 10, No 1 (2017) | THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT | Abstract PDF (Rus) |
| V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova | ||
| Vol 16, No 3 (2023) | The prospects for the use of vitamin B12 derivatives in pharmacology | Abstract PDF (Rus) |
| I. Yu. Torshin, O. A. Gromova, L. A. Maiorova | ||
| Vol 15, No 1 (2022) | The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies | Abstract PDF (Rus) |
| A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem | ||
| Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
| Vol 16, No 3 (2023) | The role of ferritin in liver disease assessment | Abstract PDF (Rus) |
| V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik | ||
| Vol 15, No 3 (2022) | The role of real world data and real world evidence in health technology assessment | Abstract PDF (Rus) |
| E. A. Novoderezhkina, S. К. Zyryanov | ||
| Vol 18, No 1 (2025) | The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market | Abstract PDF (Rus) |
| I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya | ||
| Vol 13, No 4 (2020) | The social-economic burden of spinal muscular atrophy in Russia | Abstract PDF (Rus) |
| A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina | ||
| Vol 10, No 4 (2017) | THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE | Abstract PDF (Rus) |
| Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva | ||
| Vol 10, No 3 (2017) | The strategies of drug supply for patients with chronic hepatitis C | Abstract PDF (Rus) |
| E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin | ||
| Vol 10, No 2 (2017) | THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS | Abstract PDF (Rus) |
| V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko | ||
| Vol 10, No 1 (2017) | THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES | Abstract PDF (Rus) |
| N. Z. Musina, V. K. Fedyaeva | ||
| Vol 12, No 1 (2019) | The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation | Abstract PDF (Rus) |
| N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh | ||
| Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract PDF (Rus) |
| E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
| Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract PDF (Rus) |
| G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
| Vol 18, No 1 (2025) | Trends in the industry of clinical trials | Abstract PDF (Rus) |
| S. S. Milovanov, V. V. Popov, N. V. Teplova | ||
| Vol 5, No 1 (2012) | UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES | Abstract |
| A. Y. Kulikov, A. G. Voskanyan | ||
| Vol 15, No 4 (2022) | Unified system and classification of indicators for integral assessment of the performance and effectiveness of medical care organization at the regional level in the Russian Federation | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, I. А. Mikhailov, D. V. Lukyantseva, Е. S. Samsonova, G. G. Lebedenko | ||
| Vol 16, No 1 (2023) | Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 | Abstract PDF (Rus) |
| D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin | ||
| Vol 16, No 3 (2023) | Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract PDF (Rus) |
| S. K. Zyryanov, I. N. Dyakov | ||
| Vol 11, No 3 (2018) | Use of medications in children hospitalized with community-acquired pneumonia | Abstract PDF (Rus) |
| D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova | ||
| Vol 6, No 4 (2013) | Using indirect comparisons in pharmacoeconomic examination | Abstract PDF (Rus) |
| Yu. E. Balykina, A. S. Kolbin | ||
| Vol 5, No 1 (2012) | VI CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION» | Abstract PDF (Rus) |
| Vol 5, No 2 (2012) | VI Конгресс с международным участием «Развитие фармакоэкономики и фармакоэпидемиологии в Российской Федерации» | Abstract PDF (Rus) |
| Vol 6, No 1 (2013) | VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION» | Abstract PDF (Rus) |
| Vol 6, No 2 (2013) | VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION» | Abstract PDF (Rus) |
| Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract PDF (Rus) |
| A. S. Kolbin, A. A. Kurylev | ||
| 451 - 500 of 518 Items | << < 5 6 7 8 9 10 11 > >> | |
Browse Title Index
Popular articles
Vol 10, No 1 (2017)
Vol 17, No 3 (2024)
Vol 16, No 3 (2023)
Vol 16, No 4 (2023)
Vol 18, No 1 (2025)
Vol 13, No 1 (2020)
Keywords
COVID-19
NAFLD
budget impact
budget impact analysis
chemotherapy
children
chondroitin sulfate
clinical and economic analysis
cost minimization analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
drugs
evidence-based medicine
glucosamine sulfate
health technology assessment
pharmacoeconomic analysis
pharmacoeconomics
pharmacoepidemiology
pharmacoinformatics
quality of life
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
